University of Tasmania

File(s) under permanent embargo

NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand

journal contribution
posted on 2023-05-21, 01:50 authored by Bukhari, W, Khalilidehkordi, E, Mason, DF, Barnett, MH, Bruce TaylorBruce Taylor, Fabis-Pedrini, M, Kermode, AG, Subramanian, S, Waters, P, Broadley, SA, Abernethy, D, Bhuta, S, Blum, S, Boggild, M, Boundy, K, Brew, BJ, Brilot, F, Brownlee, WJ, Bundell, CS, Butzkueven, H, Carroll, WM, Chen, C, Clarke, L, Coulthard, A, Dale, RC, Das, C, Dear, K, Fulcher, D, Gillis, D, Hawke, S, Heard, R, Henderson, APD, Heshmat, S, Hodgkinson, S, Jimenez Sanchez, S, Kilpatrick, TJ, King, J, Kneebone, C, Kornberg, AJ, Lechner-Scott, J, Lin, MW, Lynch, C, Macdonell, RAL, Marriott, MP, McCombe, PA, Oa Gorman, C, Parratt, JDE, Pender, MP, Pereira, J, Pollard, JD, Prain, KM, Ramanathan, S, Reddell, SW, Shaw, C, Silvestrini, RA, Slee, M, Spies, J, Jim Stankovich, Sutton, I, Vincent, A, Vucic, S, Walsh, M, Willoughby, E, Wong, RC, Woodhall, M, Yiu, EM

Background: We studied the prevalence of neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) in Indigenous populations of Australia and New Zealand with the aim of assessing potential differences.

Methods: Cases of possible NMOSD and MS were collected from Australia and New Zealand. Clinical details, MR imaging, and serologic results were used to apply 2015 IPND diagnostic criteria for NMOSD and 2010 McDonald criteria for MS. Frequencies of self-determined ethnic ancestry were calculated for confirmed NMOSD, suspected NMOSD, and MS. Prevalence rates for NMOSD and MS according to ancestry were compared.

Results: There were 75 cases with NMOSD, 89 with suspected NMSOD, and 101 with MS. NMOSD cases were more likely to have Asian, Indigenous, or Other ancestry compared to suspected NMOSD or MS. There were no differences in the clinical phenotype of NMOSD seen in Indigenous compared to European ancestry populations. Per 100,000, the prevalence estimate for NMOSD in people with Māori ancestry was 1.50 (95% CI 0.52–2.49) which was similar to those with Asian ancestry 1.57 (95% CI 1.15–1.98). NMOSD prevalence in Australian Aboriginal and Torres Strait Islander populations was 0.38 (95% CI 0.00–0.80) per 100,000.

Conclusion: The prevalence of NMOSD in the Māori population is similar to South East Asian countries, reflecting their historical origins. The prevalence of MS in this group is intermediate between those with South East Asian and European ancestry living in New Zealand. Both NMOSD and particularly MS appear to be uncommon in the Indigenous populations of Australia.


Publication title

Journal of Neurology




Menzies Institute for Medical Research


Dr Dietrich Steinkopff Verlag

Place of publication

Po Box 10 04 62, Darmstadt, Germany, D-64204

Rights statement

© Crown 2021

Repository Status

  • Restricted

Socio-economic Objectives

Diagnosis of human diseases and conditions

Usage metrics

    University Of Tasmania


    Ref. manager